References
- AlbertSMGurlandBMaestreGJacobsDMSternYMayeuxRApoE genotype influences functional status among elderly without dementiaAm J Med Genet1995605835878825902
- BerlauDJCorradaMMHeadEKawasCHApoE E2 is associated with intact cognition but increased Alzheimer pathology in the oldest oldNeurology20097282983419255410
- BerlauDJKahle-WrobleskiKHeadEGoodusMKimRKawasCDissociation of neuropathologic findings and cognition. Case report of an apolipoprotein E E2/E2 genotypeArch Neurol2007641193119617698712
- BlackerDLeeHMuzikanskyANeuropsychological measures in normal individuals that predict subsequent cognitive declineArch Neurol20076486287117562935
- Bonner-JacksonAOkonkwoOTremontGAlzheimer’s Disease Neuroimaging InitiativeApolipoprotein Eε2 and functional decline in amnestic mild cognitive impairment and Alzheimer diseaseAm J Geriatr Psychiatry20122058459321685781
- BorensteinARMortimerJADingDEffects of apolipoprotein E ε4 and ε2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-PAm J Alzheimers Dis Other Demen201025235238
- CorderEHSaundersAMRischMJProtective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseNat Genet199471801847920638
- FarrerLACupplesLAHainesJLEffects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysisJAMA1997278349356
- HymanBTGomez-IslaTBriggsMApolipoprotein E and cognitive change in an elderly populationAnn Neurol19964055668687193
- KulminskiAUkraintesevaSVArbeevKGAssociation between ApoE ε2.ε3/ε4 polymorphism and disability severity in a national long-term care survey sampleAge Ageing20083728829318250093
- OkonkwoOCAloscoMLJerskeyBASweetLHOttBRTremontGAlzheimer’s Disease Neuroimaging InitiativeCerebral atrophy, apolipoprotein E ε4, and rate of decline in everyday function among patients with amnestic mild cognitive impairmentAlzheimers Dement2010640441120813341
- RebekGWKindyMLaDucMJApolipoprotein E and Alzheimer’s disease: the protective effects of ApoE2 and E3J Alzheimers Dis2002414515412226533
- SmallBJRosnickCBFratiglioniLBackmanLApolipoprotein E and cognitive performance: a meta-analysisPsychol Aging20041959260015584785
- SwanGELessov-SchlaggarCNCarmelliDSchellenbergGDLa RueAApolipoprotein E ε4 and change in cognitive functioning in community-dwelling older adultsJ Geriatr Psychiatry Neurol20051819620116306239
- WilsonRSBieniasJLBerry-KravisEThe apolipoprotein E ε2 allele and decline in episodic memoryJ Neurol Neurosurg Psychiatry20027367267712438469
- SchwabRSEnglandACJrProjection techniques for evaluating surgery in Parkinson’s diseaseRoyal College of Surgeons in Edinburgh520-221968E. & S. Livingstone Ltd 1969 Available from:http://viartis.net/parkinsons.disease/schwab.england.pdfAccessed August 21, 2013
- MahoneyFIBarthelDWFunctional evaluation: the Barthel IndexMaryland State Med J1965146165 Available from: http://www.healthcare.uiowa.edu/igec/tools/function/barthelADLs.pdfAccessed August 21, 2013
- BlessedGTomlinsonBERothMThe association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjectsBr J Psychiatry19681147978115662937
- NouriFMLincolnNBAn extended activities of daily living scale for stroke patientsClin Rehabil19871301305
- FolsteinMFFolsteinSEMcHughPEMini-mental state. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res1975121891981202204
- NasreddineZSPhillipsNABédirianVThe Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairmentJ Am Geriatr Soc20055369569915817019
- MathuranathPSNestorPJBerriosGERakowiczWHodgesJRA brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementiaNeurology2000551613162011113213
- McCuskerJColeMBellavanceFPrimeauFThe reliability and validity of a new measure of severity of deliriumInt Psychogeriatr1998104214339924835
- LinnBSLinnMWGurelLCumulative Illness Rating ScaleJ Am Geriatr Soc1968166226265646906